Please check your internet connection and try again.
# Meftal-Spas
## Overview
Meftal-Spas is a fixed-dose combination (FDC) medication typically containing **Mefenamic Acid (250 mg)**, a non-steroidal anti-inflammatory drug (NSAID), and **Dicyclomine Hydrochloride (10 mg)**, an antispasmodic/anticholinergic agent. It acts via prostaglandin inhibition and direct smooth muscle relaxation.
## Primary Indications
* Symptomatic relief of painful menstrual cramps (dysmenorrhea).
* Gastrointestinal or abdominal colic/spasms.
## Adult Dosing
* **Standard Dose:** 1 tablet (250 mg Mefenamic Acid / 10 mg Dicyclomine) taken orally 3 to 4 times daily.
* **Maximum Dose:** Do not exceed 4 tablets in 24 hours.
* **Duration:** Limit use to the shortest duration necessary to control symptoms, typically not exceeding 3 to 5 days.
## Pediatric Dosing
* **Safety Note:** Use is generally **not recommended** in children due to potential for significant anticholinergic effects (dicyclomine) and NSAID-related toxicities.
* Manufacturer guidance varies by region; always consult local pediatric guidelines or a specialist before administration.
## Dose Adjustments
* **Renal Impairment:** Contraindicated in patients with severe renal failure. Use with extreme caution in mild-to-moderate impairment.
* **Hepatic Impairment:** Use with caution. If hepatic function is significantly compromised, the NSAID component may exacerbate underlying issues.
* **Geriatric:** Use with caution. Increased risk of anticholinergic side effects (e.g., urinary retention, confusion, constipation).
## Contraindications
* Hypersensitivity to Mefenamic Acid, Dicyclomine, or aspirin/NSAIDs.
* History of GI bleeding, ulceration, or inflammatory bowel disease (IBD).
* Cardiac conditions (unstable angina, history of CABG).
* Obstructive uropathy or gastrointestinal obstruction.
* Glaucoma, myasthenia gravis, or paralytic ileus.
* Third trimester of pregnancy.
## Adverse Effects
* **NSAID-related:** Epigastric pain, nausea, peptic ulceration, occult blood loss, headaches, and increased CV thrombosis risk.
* **Dicyclomine-related:** Dry mouth, blurred vision, tachycardia, urinary retention, dizziness, drowsiness, and confusion.
## Key Drug Interactions
* **Anticoagulants (e.g., Warfarin):** Increased risk of bleeding.
* **Other NSAIDs/Aspirin:** Increased risk of GI toxicity and nephrotoxicity.
* **Antihistamines/Tricyclic Antidepressants:** May potentiate anticholinergic effects of dicyclomine.
* **Lithium/Methotrexate:** NSAIDs may decrease clearance, increasing toxicity risk.
* **SSRIs:** Increased risk of gastrointestinal bleeding.
## Monitoring
* Monitor for signs of GI bleeding (black/tarry stools, hematemesis).
* Assess blood pressure and renal function during prolonged or recurrent use.
* Monitor for signs of anticholinergic toxicity (extreme dry mouth, confusion, difficult urination).
## Clinical Pearls
* **Administration:** Take with food or milk to minimize gastric irritation.
* **Avoidance:** Avoid alcohol, as it may enhance sedation and the risk of gastric irritation.
* **Warning:** Stop use immediately if signs of skin rash, respiratory distress, or severe abdominal pain occur.
* **Non-specific treatment:** This is a symptomatic relief medication. Underlying causes of severe, recurring abdominal or menstrual pain should be investigated by a physician.
***
**Educational Disclaimer:** This information is for educational purposes only. Drug availability, approved indications, and dosing protocols vary by country and local regulatory authorities. Always verify current prescribing information in the official product monograph or consult a licensed healthcare professional before prescribing or administering any medication.
